Fate Therapeutics (FATE) FCF Margin (QoQ) (2013 - 2026)
Fate Therapeutics (FATE) FCF Margin (QoQ) (2013 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
| 10 |
Fate Therapeutics |
250.86 Mn |
250.86 Mn |
- |
| Date | Value |
|---|
| Mar 31, 2026 |
-101,868.00 |
| Dec 31, 2025 |
17,131.00 |
| Sep 30, 2025 |
-13,744.00 |
| Jun 30, 2025 |
72,656.00 |
| Mar 31, 2025 |
-61,442.00 |
| Dec 31, 2024 |
-54,701.00 |
| Sep 30, 2024 |
-47,588.00 |
| Jun 30, 2024 |
125,484.00 |
| Mar 31, 2024 |
9,646.00 |
| Dec 31, 2023 |
16,819.00 |
| Sep 30, 2023 |
129,176.00 |
| Jun 30, 2023 |
-323,523.00 |
| Mar 31, 2023 |
11,349.00 |
| Dec 31, 2022 |
7,793.00 |
| Sep 30, 2022 |
13,156.00 |
| Jun 30, 2022 |
-812.00 |
| Mar 31, 2022 |
4,697.00 |
| Dec 31, 2021 |
-27,985.00 |
| Sep 30, 2021 |
20,457.00 |
| Jun 30, 2021 |
-6,201.00 |
